Andrew Strand, DO
Ophthalmology · Evansville, INNPI 1295077402
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,687 of the $11,938 with a category attached, or 72.8%. Regeneron Healthcare Solutions, Inc. accounts for 77.5% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $7,604, more than ten times the $23 reported in 2019. Among ophthalmology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 99 payments — averaging $120.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$9K
- Alimera Sciences, Inc.$707
- Carl Zeiss Meditec USA, Inc.$617
- Genentech USA, Inc.$574
- Alcon$173
- Astellas Pharma US Inc$95
- plus $518 from 13 others
Across 1 payment — averaging $8549.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$9K
What the payments were for
- Speaking & faculty fees$8,68773%
- Food & beverage$2,73723%
- Other$5144%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 25 | $9,254 |
| Alimera Sciences, Inc. | 14 | $707 |
| Carl Zeiss Meditec USA, Inc. | 5 | $617 |
| Genentech USA, Inc. | 21 | $574 |
| Alcon | 3 | $173 |
| Astellas Pharma US Inc | 4 | $95 |
| Biogen | 5 | $88 |
| Novartis | 6 | $85 |
| Regeneron | 1 | $75 |
| Bausch & Lomb Americas Inc. | 3 | $55 |
| AbbVie | 2 | $41 |
| Coherus Oncology, Inc. | 2 | $38 |
| Apellis Pharmaceuticals, Inc. | 2 | $32 |
| Amgen | 1 | $24 |
| Harrow Eye, LLC | 1 | $20 |
| Neurotech Pharmaceuticals, Inc. | 1 | $19 |
| Eyepoint US, Inc. | 1 | $15 |
| Aerie Pharmaceuticals, Inc. | 1 | $13 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EYLEA HD$8,687
- LUMERA 700$514
- Iluvien$509
- VABYSMO$147
- AcrySof IQ PanOptix$137
How this compares
$11,938 in reported general payments places this provider in the 90th percentile of 266 ophthalmology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 244 | $8,933 |
| Brimonidine Tartrate | 30 | $1,543 |
| Ketorolac Tromethamine | 62 | $1,355 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 18 | $1,301 |
| Tobramycin | 151 | $836 |
| Latanoprost | 139 | $799 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 17 | $251 |
| Dorzolamide Hcl | 13 | $168 |
| Timolol Maleate | 29 | $165 |
| Ondansetron OdtOndansetron | 20 | $133 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $98 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Evansville
- Omar DukarEvansville$43K
- Dwight SilveraEvansville$28K
- David MalitzEvansville$12K
- Drew SommervilleEvansville$8K
- Matthew BoyerEvansville$6K
- Karishma HabbuEvansville$4K
- Jonathan WeyerEvansville$4K
- Sally PrimusEvansville$4K
- Shamik BafnaLafayette$505K
- Kevin WaltzIndianapolis$199K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.